GLP-1 MARKETING.
FOR TELEHEALTH
WEIGHT LOSS.

I connect the offer, creative, advertising accounts, landing pages, CRM follow-up, and acquisition reporting. The priority depends on your bottleneck: getting qualified interest, converting that interest, or understanding what a new customer costs. We agree on the work I own and the work your team or specialist partners deliver, so strategy translates into an accountable execution plan.

Yes. We start with your actual service, approved markets, pricing, consultation journey, and operating capacity. Then we map the website, account setup, creative, inquiry routing, and measurement needed for launch. Your clinical and legal team confirms care delivery and prescribing requirements; marketing readiness does not establish clinical readiness. An existing brand starts with its current funnel and performance baseline.

Eligibility depends on the service, location, products, and destination. For US telemedicine providers facilitating prescribing, Google currently lists LegitScript certification and Google healthcare certification requirements. I review account and destination readiness before planning spend and coordinate unresolved requirements with your team. Certification is not a promise that every ad, claim, or product will be approved.

I build briefs around the service, the consultation process, pricing clarity, and questions prospective customers actually ask. Each concept has a defined message, destination, and review owner. Your qualified advisers review treatment claims before publication. We assess each channel’s current requirements, then test permitted creative against downstream outcomes rather than judging a campaign only by clicks.

Track the steps separately: inquiry, qualified inquiry, booked consultation, attendance where available, and first purchase. Document where clinical intake begins and who owns each handoff. A low lead cost can hide poor qualification or missed consultations. I use the stage-by-stage view to identify whether the next improvement belongs in the ad, landing page, response process, or booking experience.

Define a new customer as a first-time purchaser in the agreed source of truth, then distinguish subsequent transactions from that acquisition event. I connect campaign naming, CRM stages, revenue records, and attribution tools such as Wicked Reports where appropriate. Reports should state the date range, attribution model, cost basis, and matching limitations; blended revenue alone cannot tell you what it cost to acquire a new customer.

Your allowable acquisition cost depends on collected revenue, contribution margin, retention, refunds, and the time you can afford to wait for payback. We establish a target from your economics and compare it with observed first-time customer acquisition. I do not turn a broader healthcare case study into a GLP-1 benchmark or promise the same CAC for every offer.

Yes. Organic work can cover service-page structure, useful buyer questions, internal links, technical crawlability, and conversion paths. Paid activity depends on channel eligibility and the economics of your offer. We give each channel a clear role and review its contribution separately, including email and organic search, so repeat business is not mistaken for newly acquired demand.

Start with three separate budgets: marketing leadership and execution, media spend, and software or production requirements. My fractional CMO engagements are scoped in the $5,000–$10,000 monthly range. The proposal defines the included work and any separate costs. A media budget follows your allowable acquisition cost, testing needs, and service capacity; a universal spend recommendation would skip those decisions.

The first phase reviews your offer, accounts, funnel, reporting, and operational handoffs. We prioritize the largest supported constraint, assign owners, and define what a useful test should show. Setup improvements can be verified as they are completed; acquisition performance needs sufficient delivery and conversion data. I agree on milestones and reporting with you rather than guaranteeing a launch date, patient volume, or ranking.